Cryo-Cell and EndGenitor sign research collaboration
The research will focus on the utilization of cord blood and menstrual blood derived cells, known as ECFCs and MenSCs, respectively. ECFCs are cord blood-derived endothelial colony-forming cells.
Novartis has signed an agreement to purchase Myricx Bio, a UK-based biotechnology company, in a transaction valued at up to $1.5bn.
The randomized, double-blind, placebo-controlled Phase III study is evaluating Nexavar (sorafenib) tablets as adjuvant treatment, which is treatment following surgery or local radiation, for patients with hepatocellular carcinoma